Singular Genomics Systems...

NASDAQ: OMIC · Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM

Singular Genomics Systems Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.91M 765K n/a
Cost of Revenue
3.47M 789K 1.13M
Gross Profit
-558K -24K -1.13M
Operating Income
-102.8M -93.49M -61.28M
Interest Income
9.08M 3.37M 328K
Pretax Income
-94.82M -90.88M -98.77M
Net Income
-94.82M -88.27M -98.89M
Selling & General & Admin
54.48M 47.26M 28.62M
Research & Development
47.76M 46.2M 32.66M
Other Expenses
n/a n/a 405K
Operating Expenses
102.24M 93.46M 61.28M
Interest Expense
1.1M 763K 846K
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
105.71M 94.25M 61.28M
Income Tax Expense
n/a -2.61M 118K
Shares Outstanding (Basic)
2.43M 2.37M 2.41M
Shares Outstanding (Diluted)
2.43M 2.37M 2.41M
EPS (Basic)
-39.08 -37.22 -40.95
EPS (Diluted)
-39.08 -37.22 -40.95
EBITDA
-86.5M -84.08M -60.55M
EBIT
-93.72M -90.12M -97.92M
Depreciation & Amortization
7.22M 6.03M 1.13M